The joint resolution instructs the President to terminate U.S. armed forces’ involvement in hostilities against any foreign terrorist organization , specially designated global terrorist , or state where such entities operate, and against non‑state groups engaged in drug trafficking, unless Congress issues a declaration of war or a specific statutory authorization. It emphasizes that the mere designation of an organization does not grant the President authority to use force and that the recent strikes on vessels in September 2025 are considered hostilities under the War Powers Resolution. Congress notes that it has not received adequate information about the vessels’ affiliations, threats, or available non‑lethal options, and therefore requires a clear congressional mandate before further military action. The resolution also calls for resources and authorities to aid the executive branch in combating drug trafficking through intelligence, law enforcement, and diplomatic or military tools, while allowing the President to request additional support. The rule of construction clarifies that the directive does not preclude the U.S. from defending itself against an armed attack or from using forces in support of civil authorities during authorized counternarcotics operations. It underscores that drug trafficking alone does not constitute an armed attack or imminent threat, and therefore cannot justify military engagement without congressional approval. The resolution is to be processed under expedited procedures outlined in the Department of State Authorization Act and the International Security and Arms Control Export Act.